2024 Nov 15 - The RNAscope ISH Breakthrough: When Clarity Matters
Jordan Laser, MD
Sr. Director, Clinical and Medical Affairs Diagnostics and Genomics Segment, Bio-Techne
Watch Video:
Robert Monroe, MD, PhD
VP and Chief Scientific Officer of Oncology, Danaher Diagnostics and CMO, Leica Biosystems
Outline:
In this roundtable discussion, pathologists Dr. Monroe and Dr. Laser provide an overview of RNAscope technology and how it is shaping the molecular in situ hybridization (ISH) testing landscape. Attendees will see how RNAscope RNA ISH, coupled with automation capability on the BOND platform, takes ISH to the next level.
Learning Objectives:
- Understand the significance of ISH and its traditional role in diagnostic testing as a valuable tool for obtaining a comprehensive diagnostic picture.
- Learn about the evolution of ISH, focusing on how RNAscope technology has successfully progressed the capabilities of traditional ISH through its potential to provide higher sensitivity and specificity in RNA detection.
- See the ISH difference for yourself as RNAscope is put into context and comes alive with slide images. You will see how the technology allows for highly specific target recognition and amplification of RNA signals.
